BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28625477)

  • 1. Challenges and advances in the diagnosis, biology, and treatment of urothelial upper tract and bladder carcinomas.
    Aragon-Ching JB
    Urol Oncol; 2017 Jul; 35(7):462-464. PubMed ID: 28625477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000.
    David KA; Mallin K; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
    Cancer; 2009 Apr; 115(7):1435-47. PubMed ID: 19215030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unusual clinical presentation of upper urothelial carcinoma in Taiwan.
    Chou YH; Huang CH
    Cancer; 1999 Mar; 85(6):1342-4. PubMed ID: 10189140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urothelial cancer of the urinary bladder: can lessons learned be applied to the upper urinary tract?
    Krabbe LM; Hutchinson RC; Margulis V
    Minerva Urol Nefrol; 2016 Aug; 68(4):396-408. PubMed ID: 26990295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transitional cell carcinoma of the urinary tract: radiologic-pathologic correlation.
    Wong-You-Cheong JJ; Wagner BJ; Davis CJ
    Radiographics; 1998; 18(1):123-42; quiz 148. PubMed ID: 9460113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urothelial carcinoma of the bladder and the upper tract: disparate twins.
    Green DA; Rink M; Xylinas E; Matin SF; Stenzl A; Roupret M; Karakiewicz PI; Scherr DS; Shariat SF
    J Urol; 2013 Apr; 189(4):1214-21. PubMed ID: 23023150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-urothelial tumors of the urinary tract].
    Mikuz G
    Verh Dtsch Ges Pathol; 1993; 77():180-98. PubMed ID: 7511278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular changes in development and progression of urothelial carcinoma].
    Hartmann A
    Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upper urinary tract urothelial carcinoma in eastern Taiwan: high proportion among all urothelial carcinomas and correlation with chronic kidney disease.
    Chen CY; Liao YM; Tsai WM; Kuo HC
    J Formos Med Assoc; 2007 Dec; 106(12):992-8. PubMed ID: 18194904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. News in the classification of WHO 2022 bladder tumors.
    Raspollini MR; Comperat EM; Lopez-Beltran A; Montironi R; Cimadamore A; Tsuzuki T; Netto GJ
    Pathologica; 2022 Feb; 115(1):32-40. PubMed ID: 36704871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-urothelial and urothelial variants of bladder cancer.
    Yu EM; Belay S; Li W; Aragon-Ching JB
    Cancer Treat Res Commun; 2022; 33():100661. PubMed ID: 36442362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel therapeutic targets in advanced urothelial carcinoma.
    Rouanne M; Loriot Y; Lebret T; Soria JC
    Crit Rev Oncol Hematol; 2016 Feb; 98():106-15. PubMed ID: 26589398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new era in the treatment of urothelial carcinoma.
    Faltas B
    Urol Oncol; 2023 Oct; 41(10):395-397. PubMed ID: 37833099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for bladder cancer recurrence after nephroureterectomy for upper tract urothelial tumors: results from the Canadian Upper Tract Collaboration.
    Fradet V; Mauermann J; Kassouf W; Rendon R; Jacobsen N; Fairey A; Izawa J; Kapoor A; Black P; Tanguay S; Chin J; So A; Lattouf JB; Bell D; Saad F; Sheyegan B; Drachenberg D; Cagiannos I; Lacombe L
    Urol Oncol; 2014 Aug; 32(6):839-45. PubMed ID: 24856978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upper tract urothelial tumors. Diagnostic efficiency of radiology and urinary cytology.
    Boccon Gibod L; Chiche R; Dalian D; Steg A
    Eur Urol; 1982; 8(3):145-7. PubMed ID: 7075632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recurring urothelial tumours of the urinary tract (author's transl)].
    Flamm J
    Wien Med Wochenschr; 1979 Oct; 129(19):535-40. PubMed ID: 516751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence in situ hybridization: a multitarget approach in diagnosis and management of urothelial cancer.
    Arentsen HC; de la Rosette JJ; de Reijke TM; Langbein S
    Expert Rev Mol Diagn; 2007 Jan; 7(1):11-9. PubMed ID: 17187480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biological complexity of urothelial carcinoma: Insights into carcinogenesis, targets and biomarkers of response to therapeutic approaches.
    Grivas PD; Melas M; Papavassiliou AG
    Semin Cancer Biol; 2015 Dec; 35():125-32. PubMed ID: 26304731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are urothelial carcinomas of the upper urinary tract a distinct entity from urothelial carcinomas of the urinary bladder? Behavior of urothelial carcinoma after radical surgery with respect to anatomical location: a case control study.
    Kim M; Jeong CW; Kwak C; Kim HH; Ku JH
    BMC Cancer; 2015 Mar; 15():149. PubMed ID: 25886012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.